← Back to search
ZYMERON CORPORATION
DURHAM, NC, 27709
Unclaimed
Minority Owned
AI-Generated Company Overview
Generating overview from available records...
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Prime contracting experience
8 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Defense Defense Health Agency | DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS HT942524C0057 | — | $2,999,983 | May 21, 2026 | Sep 20, 2024 – Jul 19, 2027 |
| Prime | Department of Defense Defense Health Agency | DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK" HT942523C0067 | — | $2,999,999 | Apr 16, 2025 | Sep 15, 2023 – Jan 14, 2026 |
| Prime | Department of Defense Defense Health Agency | AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME" W81XWH22C0012 | — | $2,999,993 | Mar 17, 2025 | Feb 7, 2022 – Jun 6, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. 75N93021C00035 | — | $1,272,000 | Mar 13, 2024 | Aug 12, 2021 – Mar 15, 2024 |
| Prime | Department of Defense Defense Health Agency | ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT HT942523P0041 | — | $250,000 | Dec 15, 2023 | Jun 30, 2023 – Jan 29, 2024 |
| Prime | Department of Defense Defense Health Agency | DHA STTR PH I PROPOSAL H23B-001-0020 ,TOPIC DHA23B-001-0020 TITLE AN AUTOMATED BLOOD-IN, MIRNAS-OUT ASSAY TO DETECT CIRCULATING AND EXOSOME MIRNAS EGS 2300543 MEDICAL R AND D HT942524P0004 | — | $250,000 | Oct 4, 2023 | Oct 6, 2023 – May 5, 2024 |
| Prime | Department of Defense Defense Advanced Research Projects Agency | AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD HR001122C0128 | — | $989,815 | Jun 29, 2023 | Aug 26, 2022 – Aug 25, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | THE CONTRACTOR SHALL PROPOSE NOVEL, LOW-COST, REAL-TIME POINT-OF-CARE (POC) ASSAYS FOR HIV VIRAL LOAD MONITORING, HIV DRUG RESISTANCE MONITORING, AND PHARMACOLOGICAL ADHERENCE MONITORING. 75N93021C00030 | — | $299,988 | Jun 8, 2023 | Jul 1, 2021 – Jun 30, 2024 |
Contract vehicles are shown only when present in the source record.
Subcontracting experience
No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.
Agencies supported
- Department of DefenseGov-sourced
- Department of Health and Human ServicesGov-sourced